Alberto Alvarado

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 16 EPO patents. Top assignees: Eli Lilly and Company, Verenium Corporation, Basf Enzymes LLC. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Alvarado. Retrieved from https://idiyas.com/inventor/alberto-alvarado

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 18)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

3 out of 4,514

Eli Lilly and Company

Years Active: 2014-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10808027 - DNA molecules encoding antibodies to tau and methods of making thereof (2020-10-20),

2. 10196617 - Phytases, nucleic acids encoding them and methods for making and using them (2019-02-05),

3. 10011653 - Antibodies to tau and methods of treatment therewith (2018-07-03),

4. 9527909 - Antibodies to tau and uses thereof (2016-12-27),

5. 8936924 - Methods for using a thermostable phytase in ethanol production (2015-01-20),

6. 8877478 - Phytases, nucleic acids encoding them and methods for making and using them (2014-11-04),

Title: The Innovative Contributions of Alberto Alvarado

Introduction

Alberto Alvarado is a prominent inventor based in San Diego, CA. He has made significant contributions to the fields of biotechnology and molecular biology. With a total of 6 patents to his name, Alvarado's work focuses on developing innovative solutions for various health and agricultural challenges.

Latest Patents

Alvarado's latest patents include groundbreaking inventions such as DNA molecules encoding antibodies to tau and methods of making them. This includes monoclonal antibodies to human tau aggregates, which have potential applications in treating neurodegenerative diseases like Alzheimer's disease, Progressive Supranuclear Palsy, and Pick's disease. Another notable patent involves phytases and nucleic acids encoding them. This invention relates to phytases that maintain activity under high-temperature conditions, improving the feeding value of phytate-rich ingredients in foodstuffs. These phytases can be formulated as foods, feeds, or supplements, aiding in the digestion of phytate and enhancing nutritional value.

Career Highlights

Throughout his career, Alvarado has worked with esteemed companies such as Eli Lilly and Company and Verenium Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Alvarado has collaborated with notable coworkers, including Brian Steer and Mark Dycaico. These partnerships have fostered a creative environment that has led to the development of impactful inventions.

Conclusion

Alberto Alvarado's contributions to biotechnology and molecular biology are noteworthy. His innovative patents and collaborations reflect his commitment to advancing science and improving health outcomes. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.